Cargando…

Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia

Detalles Bibliográficos
Autor principal:	Kim, Eun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323308/ https://www.ncbi.nlm.nih.gov/pubmed/28239312 http://dx.doi.org/10.5217/ir.2017.15.1.5

Ejemplares similares

Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia
por: Lee, Oh Young
Publicado: (2010)

The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia
por: Hong, Seung Wook, et al.
Publicado: (2020)

What Are the Unanswered Questions and Unmet Needs in Inflammatory Bowel Disease Management in Asia?
por: Li, Yue, et al.
Publicado: (2017)

Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
por: Lee, Ji Min, et al.
Publicado: (2022)

Viral Infections and Inflammatory Bowel Disease
por: Gorbach, Sherwood L.
Publicado: (1982)

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
por: Eun, Chang Soo
Publicado: (2017)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

Pivot to Asia: inflammatory bowel disease burden
por: Singh, Prashant, et al.
Publicado: (2017)

Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
por: Hu, Pin-Jin
Publicado: (2015)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
por: Eun, Chang Soo
Publicado: (2017)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Optimization of Inflammatory Bowel Disease Cohort Studies in Asia
por: Leung, Wai K.
Publicado: (2015)

Changing epidemiological trends of inflammatory bowel disease in Asia
por: Ng, Wee Khoon, et al.
Publicado: (2016)

Incidence and Prevalence of Inflammatory Bowel Disease across Asia
por: Park, Jihye, et al.
Publicado: (2021)

What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
por: Park, Su Bee, et al.
Publicado: (2022)

Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients
por: Kim, Seong-Eun
Publicado: (2017)

Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease
por: Abreu, Maria T, et al.
Publicado: (2020)

Simple renal cysts: no longer simple?
por: Suh, Sang Heon, et al.
Publicado: (2022)

Inflammatory Bowel Disease in Asia: A Second Chance at Uncovering Environmental Factors
por: Konkel, Lindsey
Publicado: (2016)

Association Between Inflammatory Bowel Disease and Viral Infections
por: Dehghani, Tannaz, et al.
Publicado: (2023)

Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
por: Yeo, Seong Jae, et al.
Publicado: (2018)

Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease
por: Kim, Eun Sil, et al.
Publicado: (2022)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
por: Park, Soo-Kyung, et al.
Publicado: (2020)

Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel Disease
por: Kim, Seong-Eun
Publicado: (2016)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Dietary role in the development and treatment of inflammatory bowel disease
por: Kim, Jae Young
Publicado: (2020)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia
por: Chuah, Kee‐Huat, et al.
Publicado: (2021)

Prevalence of Irritable Bowel Syndrome in East Asia: Are There Differences Between Countries?
por: Shin, Cheol Min
Publicado: (2023)

Dietary Patterns and Cardiovascular Disease Risk in Asia
por: Iso, Hiroyasu
Publicado: (2023)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?
por: Jang, Hyun Joo
Publicado: (2019)

Epidemiology of Inflammatory Bowel Diseases in Iran and Asia; A Mini Review
por: Safarpour, Ali Reza, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4dn6lb7f1on997gic4sftevtth